Welcome to the Journal of Central Nervous System Disease, a premier Open Access publication dedicated to advancing the understanding of neurological disorders and their underlying mechanisms. Published by SAGE Publications Ltd, this esteemed journal has been serving the scientific community since 2009 and is committed to disseminating high-quality research that spans from clinical neurology to cellular and molecular neuroscience. With an impressive impact factor, the journal ranks within the top quartiles—Q2 in both Neurology and Clinical Neurology, and Q3 in Cellular and Molecular Neuroscience as of 2023. The journal's indexing in Scopus reflects its significant contribution to the field, being ranked #83 out of 400 in clinical neurology and #38 out of 97 in cellular and molecular neuroscience. This essential resource, based in the United States, is crucial for researchers, clinicians, and students looking to stay at the forefront of neurological science. By providing Open Access options, we ensure that groundbreaking research is readily available to a global audience, fostering collaboration and innovation in the study of central nervous system diseases.

Multiple Sclerosis Journal, published by SAGE Publications Ltd, is a leading academic journal in the fields of neurology and clinical neurology, with an impressive impact factor reflecting its critical role in neurological research. Established in 1995 and continuing to 2024, this journal has positioned itself as a premier platform for disseminating innovative and impactful research related to multiple sclerosis, thereby contributing significantly to both clinical practice and scientific advancements in the field. The journal's robust standing is evidenced by its Q1 category rankings, placing it in the top tier of both Neuroscience (Rank #16/192, 91st Percentile) and Clinical Neurology (Rank #35/400, 91st Percentile) categories, making it an essential resource for researchers, healthcare professionals, and students alike. The journal focuses on a wide array of topics, including basic research, clinical trials, and treatment methodologies, ensuring that its readership is well-informed about the latest developments and trends. Access to its articles is through subscription, fostering a reputable environment for quality research dissemination.

Acta Epileptologica is a prominent open-access journal published by SPRINGERNATURE, dedicated to advancing research in the fields of neurology and clinical neurology. With its ISSN 2096-9384 and E-ISSN 2524-4434, this journal has established itself as a key resource for researchers and practitioners worldwide, particularly since its transition to open access in 2019. Based in the United Kingdom, Acta Epileptologica aims to disseminate high-quality research and foster scholarly collaboration, as evidenced by its consistent Q3 ranking in both neurology and clinical neurology categories as of 2023. Although currently positioned in the lower percentiles on Scopus, the journal plays a critical role in exploring emerging trends and novel therapeutic approaches in epilepsy research, making it an essential platform for academics, healthcare professionals, and students deeply invested in the evolving landscape of neurological disorders.

Cerebrovascular Diseases Extra is a distinguished open-access journal published by KARGER, operating out of Switzerland since 2011. With ISSN 1664-5456, this journal aims to bridge the gap in knowledge surrounding cerebrovascular diseases, an essential segment of both Cardiology and Cardiovascular Medicine as well as Neurology. Ranked in the third quartile by Scopus for various categories, including Cardiology, Neurology, and Clinical Neurology, it is specially designed for academics, clinicians, and researchers who seek to disseminate and gain insights into the latest advancements and research findings in these critical areas. By embracing open access, it amplifies the reach and impact of its published research, ensuring that vital information is readily accessible to a global audience. As the journal converges towards its targeted years from 2015 to 2024, it remains a pivotal platform for fostering innovative ideas and collaborative research in cerebrovascular health.

ESC Heart Failure is a premier academic journal dedicated to the field of cardiology, specifically focusing on heart failure and its management. Published by WILEY PERIODICALS, INC, this esteemed journal has been an open access publication since 2014, making cutting-edge research readily accessible to a global audience. With its impressive impact factor and recent classification as a Q1 journal in Cardiology and Cardiovascular Medicine for 2023, ESC Heart Failure stands out as a leading resource with a Scopus ranking of #68 out of 387 in its field, placing it in the 82nd percentile. The journal aims to disseminate vital research findings, reviews, and clinical insights that advance the understanding and treatment of heart failure, thereby supporting healthcare professionals, researchers, and students in enhancing patient care. Its commitment to quality and relevance makes ESC Heart Failure an essential publication for anyone involved in cardiovascular medicine.

Journal of Neurologic Physical Therapy, published by Lippincott Williams & Wilkins, stands as a premier resource in the field of physical therapy with a specific focus on neurology. With an ISSN of 1557-0576 and an E-ISSN of 1557-0584, this journal serves as a vital platform for researchers, practitioners, and students from 2004 to 2024, illustrating its commitment to advancing knowledge in neurologic rehabilitation. It holds a prestigious Q1 ranking in categories such as Physical Therapy, Sports Therapy, and Rehabilitation and Rehabilitation, alongside Q2 rankings in Geriatrics and Gerontology, Medicine (Miscellaneous), and Neurology (Clinical). With an impact factor that reflects its significance, the journal hosts comprehensive studies and clinical insights that propel practice and innovation in neurologic physical therapy. The content is designed to enhance understanding and skills, making it an indispensable resource for those dedicated to improving patient care and outcomes in this critical area of health.

CEREBROVASCULAR DISEASES is a prestigious journal published by KARGER that focuses on the critical field of cerebrovascular health, encompassing research and advancements in cardiology and neurology. With a strong emphasis on high-quality, peer-reviewed publications, the journal has established itself as an essential resource since its inception in 1987, contributing to the understanding and management of cerebrovascular disorders. It holds a commendable Q2 ranking across various categories, including Cardiology and Cardiovascular Medicine, which underscores its influence within the research community. The journal is especially significant for professionals and researchers interested in the intersection of neurological and cardiovascular health, facilitating knowledge sharing and innovative research. Although it does not operate under an Open Access model, the journal is well-regarded for its rigorous selection criteria and impactful findings. By continuing to publish cutting-edge research, CEREBROVASCULAR DISEASES aims to foster advancements in treatment and prevention strategies for cerebrovascular diseases, thereby contributing to improved patient outcomes worldwide.

Archives of Neuroscience is a multidisciplinary journal dedicated to advancing the field of neuroscience through the publication of original research articles, review papers, and case studies. Published by BRIEFLAND, this journal aims to bridge the gap between neuroscience research and clinical applications, fostering a deeper understanding of brain function, neurological disorders, and potential therapeutic approaches. With an ISSN of 2322-3944 and an E-ISSN of 2322-5769, Archives of Neuroscience serves as an essential platform for researchers, professionals, and students alike, encouraging open access to knowledge and insights that drive innovation in the field. Although coverage was discontinued in Scopus from 2016 to 2017, the journal continues to uphold rigorous standards of academic excellence, making it a valuable resource for the neuroscience community seeking to explore and disseminate new findings. The journal is committed to providing timely access to research tools and findings that are crucial for informed decision-making in both academic and clinical settings.

Physical Medicine and Rehabilitation Clinics of North America is a leading journal published by W B Saunders Co-Elsevier Inc., focusing on the multifaceted disciplines of physical medicine, rehabilitation, and related health professions. With an impressive impact factor reflecting its significant contribution to the field, this journal ranks in the Q2 quartile for both Physical Therapy and Rehabilitation categories. The journal, available in both print (ISSN: 1047-9651) and online (E-ISSN: 1558-1381), provides critical insights, clinical updates, and comprehensive reviews that are essential for researchers, practitioners, and students alike. Covering a wide spectrum of topics from innovative rehabilitation techniques to emerging trends in sports medicine, it aims to disseminate knowledge that enhances patient care and drives advancements in rehabilitation practices. With a publication history spanning from 1995 to 2024, Physical Medicine and Rehabilitation Clinics is an essential resource for those dedicated to improving functional outcomes and the quality of life for patients worldwide.

NEUROLOGY, published by Lippincott Williams & Wilkins, stands as a premier journal in the field of neurology, holding an esteemed Q1 category ranking in clinical neurology as of 2023. Established in 1951, this journal has been a critical resource for the dissemination of cutting-edge research and clinical advancements, with an impressive Scopus rank of 24 out of 400, placing it in the 94th percentile among its peers. NEUROLOGY serves as a vital platform for neurologists, researchers, and medical professionals seeking to stay abreast of the latest findings and innovations in the treatment and understanding of neurological disorders. With its rigorous peer-review process and commitment to excellence, NEUROLOGY remains essential reading for all individuals dedicated to advancing the science and practice of neurology, contributing significantly to the ongoing dialogue in this vital area of medicine.